Yatharth Hospital & Trauma Care Services Limited has reported a strong financial performance for the first quarter of fiscal year 2026, with significant growth in revenue and profitability.

Financial Highlights

• Revenue reached Rs. 2,578.00 million, marking a 22% year-on-year growth and an 11% quarter-over-quarter increase.
• Net profit surged by 38% year-on-year to Rs. 420.00 million.
• EBITDA grew by 20% year-on-year to Rs. 645.00 million, with a 25% margin.
• ARPOB (Average Revenue Per Occupied Bed) increased by 6% year-on-year to Rs. 32,395.00.

Operational Performance

• The Greater Faridabad facility turned net profit positive within one year of operations, contributing Rs. 234.00 million in revenue (9% of total).
• Inpatient volume surged 27% year-over-year, while outpatient volumes rose 20% year-over-year.
• Oncology now contributes 17% of Noida Extension's revenue and 10% of group revenue, showing 49% year-on-year growth.

Expansion and New Facilities

• The company inaugurated its New Delhi facility in July 2025.
• Plans are in place to launch the Faridabad facility in late August 2025.
• These two new facilities will add approximately 700 beds combined.

Strategic Developments

• The company resolved the Jhansi land ownership issue.
• Yatharth Hospital is transitioning to MSKA & Associates as statutory auditors.

Management Outlook

The management expects to maintain revenue growth around 30% and EBITDA margins similar to Q4 FY25 levels.

Facility-wise Performance

Yatharth Tyagi, Whole Time Director, commented on the results: "We are pleased to report another quarter of stellar performance, achieving our highest ever revenue and profitability. Our strategic initiatives and operational excellence have driven this growth, with the Greater Faridabad facility turning net profit positive within just one year of operations."

The company's focus on improving case mix and payer mix, supported by strategic investments in super speciality services, has contributed to the strong performance. Yatharth Hospital is also making significant progress in medical value travel initiatives, collaborating with international healthcare institutions and establishing information centers in various countries.

With the new hospitals in New Delhi and Faridabad set to accelerate growth from Q2 FY26 onwards, Yatharth Hospital & Trauma Care Services Limited appears well-positioned for continued expansion and improved financial performance in the coming quarters.

Yatharth Hospital & Trauma Care Services Limited has reported significant progress in utilizing the proceeds from its Qualified Institutional Placement (QIP), according to its monitoring agency report. The company has efficiently deployed Rs 4,593.37 million of the total Rs 6,039.00 million net proceeds, leaving Rs 1,445.64 million yet to be utilized.

Key Utilizations

The QIP funds have been allocated across several strategic initiatives:

1. Debt Repayment: The company has fully utilized Rs 956.80 million for repayment of borrowings, as planned.

2. Hospital Acquisitions: Rs 2,163.17 million has been spent on acquiring two hospitals, with Rs 10.68 million remaining for this purpose.

3. Medical Equipment: Rs 400.56 million has been invested in purchasing medical equipment, with Rs 1,116.80 million still available for future acquisitions.

4. General Corporate Purposes: Rs 1,072.83 million has been used, leaving Rs 318.16 million for ongoing corporate needs.

Monitoring Agency Findings

Crisil Ratings Limited, the appointed monitoring agency, reported no deviations from the disclosed objectives. All utilizations were found to be in line with the offer document, ensuring transparency and adherence to stated goals.

New Hospital Launch

In a significant milestone, Yatharth Hospital inaugurated its new facility in Model Town, Delhi. This development marks a tangible outcome of the company's expansion strategy funded by the QIP proceeds.

Fund Management

The unutilized funds, amounting to Rs 1,445.64 million, have been strategically deployed to generate returns:

Future Outlook

Yatharth Hospital plans to utilize the remaining funds primarily for purchasing medical equipment and meeting general corporate expenses. This strategic allocation is expected to further strengthen the company's operational capabilities and market position in the healthcare sector.

The company's judicious use of QIP proceeds, coupled with its expansion initiatives, demonstrates a focused approach towards enhancing its healthcare infrastructure and services. As Yatharth Hospital continues to execute its growth strategy, investors and stakeholders will be keenly watching the impact of these investments on the company's future performance and market presence.